| Literature DB >> 30073194 |
Caitlin A Orsini1, Luis M Colon-Perez1, Sara C Heshmati1, Barry Setlow1,2,3,4, Marcelo Febo1,2,4,5.
Abstract
Brain imaging studies indicate that chronic cocaine users display altered functional connectivity between prefrontal cortical, thalamic, striatal, and limbic regions; however, the use of cross-sectional designs in these studies precludes measuring baseline brain activity prior to cocaine use. Animal studies can circumvent this limitation by comparing functional connectivity between baseline and various time points after chronic cocaine use. In the present study, adult male Long-Evans rats were trained to self-administer cocaine intravenously for 6 h sessions daily over 14 consecutive days. Two additional groups serving as controls underwent sucrose self-administration or exposure to the test chambers alone. Functional magnetic resonance imaging was conducted before self-administration and after 1 and 14 d of abstinence (1d and 14d Abs). After 1d Abs from cocaine, there were increased clustering coefficients in brain areas involved in reward seeking, learning, memory, and autonomic and affective processing, including amygdala, hypothalamus, striatum, hippocampus, and thalamus. Similar changes in clustering coefficient after 1d Abs from sucrose were evident in predominantly thalamic brain regions. Notably, there were no changes in strength of functional connectivity at 1 or 14 d after either cocaine or sucrose self-administration. The results suggest that cocaine and sucrose can change the arrangement of functional connectivity of brain regions involved in cognition and emotion, but that these changes dissipate across the early stages of abstinence. The study also emphasizes the importance of including baseline measures in longitudinal functional neuroimaging designs seeking to assess functional connectivity in the context of substance use.Entities:
Keywords: cocaine; functional connectivity; network analysis; rat; resting-state fMRI; self-administration
Mesh:
Substances:
Year: 2018 PMID: 30073194 PMCID: PMC6071197 DOI: 10.1523/ENEURO.0081-18.2018
Source DB: PubMed Journal: eNeuro ISSN: 2373-2822
Figure 1.Experimental timeline showing each of the imaging sessions in relation to periods of cocaine or sucrose self-administration and abstinence.
Figure 3.Seed-based functional connectivity maps illustrating left and right hemisphere seeds for striatal and cortical regions. Maps are composite statistical maps from the chamber exposure control group at baseline. Regions showing significant functional connectivity with the seed region are displayed (uncorrected threshold, t > 2.4, p < 0.05). Green arrows indicate the seed region in each map. Each region shows 2 contiguous slices of 12 total coronal slices scanned from rostral to caudal in the brain.
Figure 5.Cocaine self-administration increases modularity, clustering, and small worldness at 1d Abs. , Node strength. , Clustering coefficient. , Modularity. , Average path length. , Small worldness. All data are the mean ± SE. *Cocaine group vs control; **sucrose group vs control at 14 Abs. Two-way repeated-measures ANOVA used with Tukey’s multiple-comparison post hoc test (α < 0.05).
Figure 6.Cocaine or sucrose self-administration increased clustering across limbic, cortical, and thalamic regions at 1d Abs. *Cocaine group vs chamber exposure controls at 1d Abs; **sucrose group vs chamber exposure controls at 1d Abs. Repeated-measures ANOVA with Tukey’s multiple-comparison test (α < 0.05).
Regions showing significant bilateral group × session interactions for clustering coefficient
| Regions | Baseline | 1d Abs | 14d Abs | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Chamber control | Sucrose SA | Cocaine SA | Chamber control | Sucrose SA | Cocaine SA | Chamber control | Sucrose SA | Cocaine SA | |
| CeA | 0.27 ± 0.02 | 0.33 ± 0.06 | 0.35 ± 0.02 | 0.29 ± 0.03 | 0.47 ± 0.06 | 0.43 ± 0.04* | 0.41 ± 0.05 | 0.31 ± 0.02 | 0.39 ± 0.06 |
| BaA | 0.28 ± 0.02 | 0.35 ± 0.04 | 0.35 ± 0.03 | 0.28 ± 0.03 | 0.41 ± 0.05 | 0.41 ± 0.05* | 0.36 ± 0.04 | 0.30 ± 0.01 | 0.31 ± 0.04 |
| NAc | 0.25 ± 0.04 | 0.33 ± 0.06 | 0.30 ± 0.03 | 0.31 ± 0.05 | 0.42 ± 0.05 | 0.49 ± 0.08* | 0.41 ± 0.06 | 0.28 ± 0.03 | 0.33 ± 0.03 |
| dHPC | 0.32 ± 0.04 | 0.42 ± 0.07 | 0.34 ± 0.04 | 0.32 ± 0.05 | 0.45 ± 0.11 | 0.46 ± 0.03* | 0.41 ± 0.03 | 0.38 ± 0.04 | 0.31 ± 0.02 |
| VP | 0.28 ± 0.02 | 0.34 ± 0.05 | 0.36 ± 0.05 | 0.30 ± 0.06 | 0.43 ± 0.04 | 0.50 ± 0.08* | 0.42 ± 0.04 | 0.31 ± 0.02 | 0.35 ± 0.04 |
| GP | 0.28 ± 0.03 | 0.31 ± 0.04 | 0.37 ± 0.04 | 0.34 ± 0.05 | 0.43 ± 0.01 | 0.47 ± 0.07 | 0.39 ± 0.05 | 0.27 ± 0.03 | 0.30 ± 0.05 |
| LH | 0.28 ± 0.02 | 0.34 ± 0.03 | 0.40 ± 0.03 | 0.30 ± 0.02 | 0.39 ± 0.05 | 0.45 ± 0.05* | 0.35 ± 0.04 | 0.31 ± 0.03 | 0.32 ± 0.04 |
| PV Thal | 0.31 ± 0.02 | 0.41 ± 0.05 | 0.39 ± 0.05 | 0.34 ± 0.05 | 0.51 ± 0.04 | 0.55 ± 0.07* | 0.42 ± 0.04 | 0.30 ± 0.02 | 0.34 ± 0.05 |
| AP Thal | 0.31 ± 0.01 | 0.45 ± 0.06 | 0.40 ± 0.04 | 0.32 ± 0.04 | 0.46 ± 0.08 | 0.58 ± 0.06* | 0.40 ± 0.03 | 0.30 ± 0.04 | 0.33 ± 0.03 |
| RN Thal | 0.29 ± 0.04 | 0.33 ± 0.07 | 0.39 ± 0.04 | 0.32 ± 0.05 | 0.43 ± 0.05 | 0.41 ± 0.04 | 0.45 ± 0.06 | 0.28 ± 0.04 | 0.34 ± 0.05 |
| MD Thal | 0.35 ± 0.03 | 0.42 ± 0.04 | 0.33 ± 0.03 | 0.32 ± 0.05 | 0.41 ± 0.05 | 0.48 ± 0.06* | 0.36 ± 0.03 | 0.32 ± 0.02 | 0.30 ± 0.02 |
| VL Thal | 0.32 ± 0.02 | 0.35 ± 0.03 | 0.38 ± 0.03 | 0.32 ± 0.04 | 0.45 ± 0.04* | 0.47 ± 0.05* | 0.40 ± 0.03 | 0.30 ± 0.00 | 0.38 ± 0.01 |
| VPM Thal | 0.27 ± 0.04 | 0.35 ± 0.06 | 0.35 ± 0.03 | 0.32 ± 0.03 | 0.57 ± 0.06* | 0.39 ± 0.08* | 0.38 ± 0.05 | 0.32 ± 0.03 | 0.34 ± 0.04 |
| LP Thal | 0.33 ± 0.02 | 0.41 ± 0.08 | 0.35 ± 0.04 | 0.31 ± 0.03 | 0.47 ± 0.10* | 0.54 ± 0.04* | 0.37 ± 0.03 | 0.26 ± 0.04 | 0.31 ± 0.02 |
| Pf Thal | 0.30 ± 0.03 | 0.39 ± 0.05 | 0.31 ± 0.03 | 0.29 ± 0.04 | 0.46 ± 0.01* | 0.51 ± 0.06* | 0.42 ± 0.07 | 0.32 ± 0.01 | 0.34 ± 0.02 |
| LG Thal | 0.33 ± 0.03 | 0.41 ± 0.04 | 0.33 ± 0.05 | 0.33 ± 0.05 | 0.47 ± 0.04 | 0.52 ± 0.04* | 0.40 ± 0.06 | 0.33 ± 0.03 | 0.37 ± 0.04 |
| PrL | 0.33 ± 0.02 | 0.36 ± 0.05 | 0.30 ± 0.02 | 0.31 ± 0.05 | 0.41 ± 0.02 | 0.40 ± 0.03 | 0.43 ± 0.06 | 0.31 ± 0.02 | 0.36 ± 0.04 |
| IL | 0.30 ± 0.03 | 0.28 ± 0.02 | 0.30 ± 0.01 | 0.31 ± 0.06 | 0.49 ± 0.12 | 0.43 ± 0.06 | 0.43 ± 0.08 | 0.28 ± 0.03 | 0.32 ± 0.04 |
| M2 | 0.29 ± 0.03 | 0.28 ± 0.00 | 0.39 ± 0.05 | 0.29 ± 0.05 | 0.33 ± 0.07 | 0.46 ± 0.06 | 0.50 ± 0.08 | 0.31 ± 0.03 | 0.36 ± 0.03 |
| S1 jw | 0.29 ± 0.03 | 0.39 ± 0.04 | 0.28 ± 0.02 | 0.31 ± 0.04 | 0.42 ± 0.04 | 0.38 ± 0.08 | 0.43 ± 0.04 | 0.30 ± 0.03 | 0.34 ± 0.05 |
| S1 ul | 0.28 ± 0.02 | 0.31 ± 0.01 | 0.37 ± 0.05 | 0.29 ± 0.03 | 0.38 ± 0.05 | 0.44 ± 0.07* | 0.40 ± 0.03 | 0.30 ± 0.04 | 0.35 ± 0.04 |
| S1 Sh | 0.29 ± 0.02 | 0.36 ± 0.03 | 0.33 ± 0.03 | 0.33 ± 0.05 | 0.44 ± 0.05 | 0.49 ± 0.07* | 0.38 ± 0.04 | 0.29 ± 0.02 | 0.32 ± 0.04 |
| S2 | 0.28 ± 0.03 | 0.33 ± 0.02 | 0.39 ± 0.05 | 0.31 ± 0.05 | 0.39 ± 0.06 | 0.48 ± 0.05* | 0.40 ± 0.03 | 0.26 ± 0.04 | 0.33 ± 0.06 |
Data are shown as the mean ± SEM for sucrose or cocaine SA rats and chamber exposure controls at baseline, 1d Abs, and 14d Abs. CeA, Central amygdala; BaA, basal amygdala; dHPC, dorsal hippocampus; VP, ventral pallidum; GP, globus pallidus; LH, lateral hypothalamus; Thal, thalamus; PV, paraventricular; AP, anteroposterior; RN, reticular nucleus; MD, mediodorsal; VL, ventrolateral; VPM, ventroposteromedial; LP, lateroposterior; Pf, parafascicular; LG, lateral genticulate; PrL, prelimbic; IL, infralimbic; M2, secondary motor; S1, primary somatosensory cortex; jw, jaw region, ul, upper lip; Sh, shoulder; S2, secondary somatosensory cortex. All regions in the table showed significant group × session interactions with a repeated-measures two-factor ANOVA (α < 0.05).
Asterisks represent the results of Tukey’s multiple-comparison post hoc test: *difference from chamber exposure controls; **difference between cocaine and sucrose groups.
Regions showing significant lateralized group × session interactions for clustering coefficient
| Regions | Baseline | 1d Abs | 14d Abs | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Chamber control | Sucrose SA | Cocaine SA | Chamber control | Sucrose SA | Cocaine SA | Chamber control | Sucrose SA | Cocaine SA | |
| LaA (R) | 0.29 ± 0.03 | 0.32 ± 0.04 | 0.30 ± 0.04 | 0.30 ± 0.02 | 0.40 ± 0.06 | 0.47 ± 0.06* | 0.40 ± 0.05 | 0.33 ± 0.02 | 0.34 ± 0.03 |
| MeA (R) | 0.31 ± 0.03 | 0.38 ± 0.06 | 0.41 ± 0.02 | 0.32 ± 0.03 | 0.43 ± 0.04 | 0.49 ± 0.06* | 0.41 ± 0.06 | 0.27 ± 0.02 | 0.32 ± 0.04 |
| DMS (L) | 0.30 ± 0.04 | 0.29 ± 0.05 | 0.39 ± 0.05 | 0.31 ± 0.05 | 0.46 ± 0.04 | 0.49 ± 0.05* | 0.44 ± 0.04 | 0.28 ± 0.02 | 0.37 ± 0.04 |
| LSept (R) | 0.30 ± 0.02 | 0.29 ± 0.03 | 0.39 ± 0.04 | 0.35 ± 0.08 | 0.37 ± 0.09 | 0.56 ± 0.07* | 0.42 ± 0.04 | 0.26 ± 0.01 | 0.32 ± 0.04 |
| AHA (R) | 0.28 ± 0.03 | 0.35 ± 0.03 | 0.34 ± 0.03 | 0.30 ± 0.03 | 0.49 ± 0.04* | 0.51 ± 0.07* | 0.41 ± 0.06 | 0.34 ± 0.05 | 0.36 ± 0.05 |
| MB (R) | 0.28 ± 0.03 | 0.37 ± 0.05 | 0.32 ± 0.02 | 0.31 ± 0.03 | 0.41 ± 0.09 | 0.51 ± 0.09* | 0.42 ± 0.05 | 0.32 ± 0.02 | 0.36 ± 0.04 |
| VM Thal (R) | 0.34 ± 0.03 | 0.43 ± 0.04 | 0.40 ± 0.03 | 0.31 ± 0.03 | 0.51 ± 0.05* | 0.52 ± 0.07* | 0.40 ± 0.06 | 0.28 ± 0.04 | 0.36 ± 0.03 |
| PThal (R) | 0.34 ± 0.03 | 0.36 ± 0.07 | 0.38 ± 0.03 | 0.32 ± 0.03 | 0.45 ± 0.08 | 0.47 ± 0.04* | 0.35 ± 0.03 | 0.29 ± 0.02 | 0.33 ± 0.03 |
| MG Thal (L) | 0.31 ± 0.02 | 0.38 ± 0.04 | 0.41 ± 0.04 | 0.36 ± 0.07 | 0.45 ± 0.05 | 0.52 ± 0.05 | 0.45 ± 0.09 | 0.38 ± 0.04 | 0.35 ± 0.04 |
| cRSC (L) | 0.39 ± 0.04 | 0.34 ± 0.03 | 0.35 ± 0.05 | 0.38 ± 0.05 | 0.60 ± 0.07* | 0.51 ± 0.05 | 0.46 ± 0.04 | 0.36 ± 0.05 | 0.36 ± 0.02 |
| M1 (L) | 0.26 ± 0.02 | 0.29 ± 0.02 | 0.29 ± 0.03 | 0.31 ± 0.04 | 0.40 ± 0.07 | 0.38 ± 0.05 | 0.45 ± 0.05 | 0.32 ± 0.02 | 0.33 ± 0.04 |
| S1 Tr (R) | 0.31 ± 0.03 | 0.44 ± 0.09 | 0.40 ± 0.06 | 0.26 ± 0.04 | 0.43 ± 0.07 | 0.48 ± 0.06* | 0.48 ± 0.09 | 0.38 ± 0.03 | 0.32 ± 0.02 |
| PRhC (L) | 0.30 ± 0.02 | 0.27 ± 0.04 | 0.30 ± 0.03 | 0.34 ± 0.02 | 0.60 ± 0.10* | 0.41 ± 0.04** | 0.39 ± 0.05 | 0.28 ± 0.02 | 0.36 ± 0.04 |
| MRN (L) | 0.35 ± 0.03 | 0.35 ± 0.05 | 0.38 ± 0.04 | 0.37 ± 0.04 | 0.44 ± 0.03 | 0.53 ± 0.04* | 0.38 ± 0.03 | 0.43 ± 0.03 | 0.34 ± 0.03 |
| Cer2 (L) | 0.38 ± 0.04 | 0.39 ± 0.04 | 0.33 ± 0.02 | 0.33 ± 0.05 | 0.49 ± 0.02* | 0.46 ± 0.05* | 0.51 ± 0.05 | 0.32 ± 0.02* | 0.35 ± 0.03* |
Data are shown as the mean ± SEM for sucrose or cocaine SA rats and chamber exposure controls at baseline, 1d Abs, and 14d Abs. R, Right; L, left; LaA, lateral amygdala; MeA, medial amygdala; DMS, dorsomedial striatum; LSept, lateral septum; AHA, anterior hypothalamic area; MB, mammillary bodies; Thal, thalamus; VM, ventromedial; Pthal, posterior thalamus; MG, medial genticulate; cRSC, caudal retrosplenial cortex; M1, primary motor cortex; S1, primary somatosensory cortex; Tr, trunk region; PRhC, perirhinal cortex; MRN, midbrain reticular nucleus; Cer2, 2nd cerebellar lobule. All regions in table showed significant group x session interactions with a repeated-measures two factor ANOVA (α < 0.05).
Asterisks represent results of Tukey’s multiple-comparison post hoc test: *difference from chamber exposure controls; **difference between cocaine and sucrose groups..
Figure 2.Self-administration behavior. , Rats increased their cocaine intake across 14 d of self-administration with daily 6 h access. , Both the cocaine and sucrose self-administration groups preferred the active nose poke over the inactive nose poke. Data are presented as the mean ± SEM.
Figure 4.Three-dimensional functional connectivity maps of the rat brain illustrating significant effects of sucrose or cocaine self-administration and Abs. , Chamber exposure controls showed no change at 1d Abs and an increase in cortical functional connectivity at 14d Abs. , The sucrose group largely showed increased connectivity in subcortical areas at 1d Abs. , The cocaine group showed increased functional connectivity in subcortical areas, including thalamic, hypothalamic, and forebrain regions at 1d Abs, whereas decreases were observed at 14d Abs. All maps are composites of n = 5-8 rats and are set at a correlation threshold (edge weight) value of 0.3. Spheres represent node strength, and line thicknesses represent edge weights.
Figure 7.No correlation between cocaine self-administration and global and regional brain clustering coefficient was observed. , Cocaine intake data for global clustering coefficient in chamber exposure controls and cocaine-treated rats. , Nose-poke data for the same groups as in . , , Nose-poke and cocaine intake correlations with regional clustering coefficients of cocaine rats. Blue circles, Baseline day; red squares, 1d Abs; black triangles, 14d Abs.